Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck EBITDA Margin 2010-2024 | MKKGY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Merck (MKKGY) over the last 10 years. The current EBITDA margin for Merck as of September 30, 2024 is .
  
Merck EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $22.74B $6.02B 26.47%
2024-06-30 $22.58B $5.84B 25.85%
2024-03-31 $22.60B $5.85B 25.87%
2023-12-31 $22.72B $5.94B 26.15%
2023-09-30 $22.91B $6.34B 27.65%
2023-06-30 $23.13B $6.45B 27.91%
2023-03-31 $23.27B $6.65B 28.59%
2022-12-31 $23.42B $6.85B 29.26%
2022-09-30 $23.58B $7.01B 29.70%
2022-06-30 $23.60B $7.08B 30.01%
2022-03-31 $23.54B $7.06B 29.98%
2021-12-31 $23.29B $7.03B 30.17%
2021-09-30 $22.79B $6.52B 28.61%
2021-06-30 $22.12B $6.74B 30.46%
2021-03-31 $20.79B $6.13B 29.47%
2020-12-31 $20.03B $5.62B 28.07%
2020-09-30 $19.42B $5.58B 28.74%
2020-06-30 $18.73B $4.81B 25.66%
2020-03-31 $18.66B $4.85B 25.99%
2019-12-31 $18.09B $4.55B 25.16%
2019-09-30 $17.42B $4.34B 24.88%
2019-06-30 $17.27B $4.19B 24.28%
2019-03-31 $17.24B $3.98B 23.10%
2018-12-31 $17.52B $4.18B 23.85%
2018-09-30 $17.87B $4.02B 22.46%
2018-06-30 $17.90B $4.59B 25.63%
2018-03-31 $17.75B $4.72B 26.61%
2017-12-31 $17.32B $4.84B 27.94%
2017-09-30 $16.90B $5.05B 29.85%
2017-06-30 $16.68B $4.66B 27.93%
2017-03-31 $16.70B $4.76B 28.48%
2016-12-31 $16.63B $4.89B 29.40%
2016-09-30 $16.29B $4.75B 29.13%
2016-06-30 $15.63B $4.54B 29.08%
2016-03-31 $14.89B $4.25B 28.54%
2015-12-31 $14.31B $3.78B 26.39%
2015-09-30 $13.91B $3.51B 25.23%
2015-06-30 $14.32B $3.50B 24.42%
2015-03-31 $14.59B $3.52B 24.15%
2014-12-31 $14.78B $3.64B 24.62%
2014-09-30 $15.11B $4.17B 27.62%
2014-06-30 $14.86B $4.42B 29.77%
2014-03-31 $14.80B $4.76B 32.19%
2013-12-31 $14.72B $4.82B 32.72%
2013-09-30 $14.64B $7.31B 49.91%
2013-06-30 $14.55B $6.65B 45.70%
2013-03-31 $14.30B $5.44B 38.02%
2012-12-31 $14.00B $7.60B 54.31%
2012-09-30 $13.66B $7.27B 53.18%
2012-06-30 $13.69B $10.25B 74.86%
2012-03-31 $13.85B $10.32B 74.54%
2011-12-31 $14.08B $10.55B 74.95%
2011-09-30 $14.47B $10.95B 75.64%
2011-06-30 $14.03B $7.98B 56.87%
2011-03-31 $13.05B $10.53B 80.64%
2010-12-31 $12.34B $9.81B 79.52%
2010-09-30 $11.61B $9.09B 78.24%
2010-06-30 $11.25B $11.25B 100.00%
2010-03-31 $11.14B $11.14B 100.00%
2009-12-31 $10.81B $10.81B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.076B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.098B 30.44
Takeda Pharmaceutical (TAK) Japan $43.496B 9.05
Astellas Pharma (ALPMY) Japan $19.237B 17.72
Sandoz Group AG (SDZNY) Switzerland $18.813B 0.00
United Therapeutics (UTHR) United States $16.715B 16.44
Summit Therapeutics (SMMT) United States $12.979B 0.00
Neurocrine Biosciences (NBIX) United States $12.933B 34.25
Shionogi (SGIOY) Japan $12.199B 12.22
Catalent (CTLT) United States $11.225B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.946B 0.00
Orion OYJ (ORINY) Finland $6.605B 18.57
Corcept Therapeutics (CORT) United States $6.376B 48.29
Ionis Pharmaceuticals (IONS) United States $5.866B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.296B 0.00
PTC Therapeutics (PTCT) United States $3.845B 0.00
Dyne Therapeutics (DYN) United States $2.996B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.730B 16.32
Catalyst Pharmaceuticals (CPRX) United States $2.619B 11.87
Centessa Pharmaceuticals (CNTA) United Kingdom $2.262B 0.00
Soleno Therapeutics (SLNO) United States $2.185B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.044B 0.00
Xencor (XNCR) United States $1.834B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.688B 0.00
Evotec AG (EVO) Germany $1.623B 0.00
Guardian Pharmacy Services (GRDN) United States $1.568B 0.00
Indivior (INDV) United States $1.566B 6.38
BioCryst Pharmaceuticals (BCRX) United States $1.518B 0.00
Ocular Therapeutix (OCUL) United States $1.490B 0.00
ARS Pharmaceuticals (SPRY) United States $1.401B 0.00
Harrow (HROW) United States $1.356B 0.00
Ardelyx (ARDX) United States $1.322B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.249B 0.00
Enliven Therapeutics (ELVN) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.004B 5.48
Avadel Pharmaceuticals (AVDL) Ireland $0.960B 0.00
Bioventus (BVS) United States $0.896B 28.31
Cronos Group (CRON) Canada $0.772B 0.00
USANA Health Sciences (USNA) United States $0.736B 13.64
Relay Therapeutics (RLAY) United States $0.735B 0.00
Oruka Therapeutics (ORKA) United States $0.734B 0.00
Esperion Therapeutics (ESPR) United States $0.721B 0.00
Altimmune (ALT) United States $0.701B 0.00
Tourmaline Bio (TRML) United States $0.656B 0.00
Elite Pharmaceuticals (ELTP) United States $0.635B 0.00
Savara (SVRA) United States $0.589B 0.00
ProKidney (PROK) United States $0.586B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.568B 0.00
Verve Therapeutics (VERV) United States $0.561B 0.00
OmniAb (OABI) United States $0.541B 0.00
Xeris Biopharma Holdings (XERS) United States $0.532B 0.00
Organogenesis (ORGO) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.478B 5.58
Theravance Biopharma (TBPH) Cayman Islands $0.472B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.467B 189.21
Akebia Therapeutics (AKBA) United States $0.443B 0.00
KalVista Pharmaceuticals (KALV) United States $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.393B 0.00
Larimar Therapeutics (LRMR) United States $0.388B 0.00
Korro Bio (KRRO) United States $0.362B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.361B 0.00
Sage Therapeutics (SAGE) United States $0.343B 0.00
Avita Medical (RCEL) United States $0.337B 0.00
4D Molecular Therapeutics (FDMT) United States $0.330B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 17.67
Aldeyra Therapeutics (ALDX) United States $0.295B 0.00
Lyell Immunopharma (LYEL) United States $0.275B 0.00
Aclaris Therapeutics (ACRS) United States $0.269B 0.00
Heron Therapeutics (HRTX) United States $0.249B 0.00
Silence Therapeutics (SLN) United Kingdom $0.248B 0.00
Lexeo Therapeutics (LXEO) United States $0.223B 0.00
Acrivon Therapeutics (ACRV) United States $0.210B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.195B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Nektar Therapeutics (NKTR) United States $0.188B 0.00
Inhibikase Therapeutics (IKT) United States $0.184B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.181B 0.00
Achieve Life Sciences (ACHV) Canada $0.156B 0.00
Telomir Pharmaceuticals (TELO) United States $0.153B 0.00
Galectin Therapeutics (GALT) United States $0.148B 0.00
Cassava Sciences (SAVA) United States $0.142B 0.00
Nanobiotix S.A (NBTX) France $0.136B 0.00
CytoDyn (CYDY) United States $0.134B 0.00
VAXART, INC (VXRT) United States $0.130B 0.00
Century Therapeutics (IPSC) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Journey Medical (DERM) United States $0.117B 0.00
Context Therapeutics (CNTX) United States $0.113B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Regulus Therapeutics (RGLS) United States $0.105B 0.00
Fractyl Health (GUTS) United States $0.105B 0.00
Avalo Therapeutics (AVTX) United States $0.104B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.100B 0.00
Assertio Holdings (ASRT) United States $0.092B 24.05
Arch Biopartners (ACHFF) Canada $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
OptiNose (OPTN) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.077B 0.00
ElectroCore (ECOR) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Protara Therapeutics (TARA) United States $0.073B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Mural Oncology (MURA) Ireland $0.068B 0.00
Iterum Therapeutics (ITRM) Ireland $0.066B 0.00
Scienture Holdings (SCNX) United States $0.064B 0.00
AlloVir (ALVR) United States $0.061B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
BioVie (BIVI) United States $0.049B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Nutriband (NTRB) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
FibroGen (FGEN) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.038B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Carisma Therapeutics (CARM) United States $0.034B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.033B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
CERo Therapeutics Holdings (CERO) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
BioLineRx (BLRX) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Talphera (TLPH) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.04
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.43